Gene-associated studies have shown a possible relationship between variants of genes related to dopamine signallings, such as catechol O-methyltransferase (COMT), monoamine oxidase (MAO), and dopamine transporter (SLC6A3), and the risk of schizophrenia [52,53]. This evidence concerns the gene SLC6A3 and schizophrenia.